2009 - Warfarin thromboprophylaxis in cancer did not reduce risk for catheter-related thrombosis

Siragusa, Sergio
July 2009
ACP Journal Club;7/21/2009, Vol. 151 Issue 1, p3
Academic Journal
The article focuses on a study investing reduction of catheter-related thrombosis by warfarin compared with no warfarin, or by dose-adjusted warfarin compared with fixed-dose warfarin in patients with cancer receiving chemotherapy through central venous catheters (CVCs). The results concluded that warfarin did not affect risk for catheter-related thrombosis.


Related Articles

  • A prospective evaluation of venous thromboembolism in patients undergoing cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. Lanuke, Kathryn; Mack, Lloyd A.; Temple, Walley J. // Canadian Journal of Surgery;Feb2009, Vol. 52 Issue 1, p18 

    Background: We sought to investigate the incidence of perioperative venous thromboembolism (VTE) — pulmonary embolism, superior mesenteris vein thrombosis and deep vein thrombosis — in patients with peritoneal carcinomatosis after cytoreductive surgery combined with hyperthermic...

  • Managements for lateral sinus thrombosis: does it need the ligation of internal jugular vein or anticoagulants? Jun Ho Lee; Seong Jun Choi; Keehyun Park; Yun-Hoon Choung // European Archives of Oto-Rhino-Laryngology;Jan2009, Vol. 266 Issue 1, p51 

    The purposes of this study were to review the clinical characteristics and treatment outcomes of patients with lateral sinus thrombosis (LST) and to discuss the need of internal jugular vein (IJV) ligation or anticoagulants. We retrospectively reviewed the charts of five patients (1 male and 4...

  • Clinical significance of determining plasma homocysteine: case-control study on arterial and venous thrombotic patients. Vučković, Biljana A.; Čabarkapa, Velibor S.; Ilić, Tatjana A.; Salatić, Iva R.; Lozanov-Crvenković, Zagorka S.; Mitić, Gorana P. // Croatian Medical Journal;2013, Vol. 54 Issue 5, p480 

    Aim To determine the differences in plasma homocysteine levels between three MTHFR 677 genotype subgroups in patients with thrombosis and in controls, as well as between patients with thrombosis and controls with the same MTHFR 677 genotype. Methods This case-control study was conducted in...

  • Review: Several factors are associated with the performance of D-dimer assays for detecting deep venous thrombosis.  // ACP Journal Club;Nov/Dec2004, Vol. 141 Issue 3, p76 

    The article addresses the question as to which factors are associated with the performance of D-dimer assays for detecting lower-extremity deep venous thrombosis (DVT) in symptomatic patients. The article adds that in symptomatic patients, biochemical and technical characteristics of the assays,...

  • ACOG Practice Bulletin on Preventing Deep Venous Thrombosis and Pulmonary Embolism. Ressel, Genevieve W. // American Family Physician;6/1/2001, Vol. 63 Issue 11, p2279 

    Focuses on a practice bulletin on the prevention of deep venous thrombosis developed by the Committee on Practice Bulletins--Gynecology of the American College of Obstetricians and Gynecologist. Review of the areas of prevention of thromboembolism in gynecologic patients; Recommendations for...

  • Exercise-Induced Changes in Coagulation and Fibrinolysis in Healthy Populations and Patients with Cardiovascular Disease. Womack, Christopher; Nagelkirk, Paul R.; Coughlin, Adam M. // Sports Medicine;2003, Vol. 33 Issue 11, p795 

    Highlights the clinical significance of coagulation and fibrinolytic responses, and adaptations in healthy individuals and patients with cardiovascular disease. Responses of coagulation to exercise; Exercise responses in fibrinolysis; Indicators of the potential for coagulation and fibrinolysis.

  • Risk Factors for Upper-Extremity Deep Venous Thrombosis. Kirchner, Jeffrey T. // American Family Physician;7/15/2000, Vol. 62 Issue 2, p432 

    Presents a study by M.H. Ellis and others on the risk factors and clinical outcomes of upper extremity thrombosis in 18 patients with spontaneous axillosubclavian thrombosis. Description of the study and its results; Conclusion that most patients with deep venous thrombosis of the upper...

  • Warfarin. Gabat, Alan G. // Review of Optometry;Oct2007 Supplement, Vol. 144, p14 

    The author reflects on the medicinal application of warfarin among thrombosis patients in the U.S. He argued that warfarin was organically developed as pesticide, particularly as a rat poison. Furthermore, he inferred that warfarin is common anticoagulant and is mostly used to treat a variety of...

  • Thrombus removal with a temporary vena caval filter in patients with acute proximal deep vein thrombosis. Noguchi, Manabu; Eishi, Kiyoyuki; Sakamoto, Ichiro; Nakamura, Satoru; Yamachika, Shiro; Hazama, Shiro; Iwamatsu, Miyoko; Hisada, Yoichi; Izumi, Kenta; Tanigawa, Kazuyoshi // Heart & Vessels;Sep2003, Vol. 18 Issue 4, p197 

    Between September 1999 and January 2001 we performed thrombus removal with the use of a temporary vena caval filter in 11 patients who had acute iliofemoral venous thrombosis. To facilitate thrombus removal, 5 patients initially received catheter-directed thrombolytic therapy (thrombolysis...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics